On March 31, 2014, the National Health and Family Planning Commission (NHFPC) of China notified the World Health Organization (WHO) of three additional laboratory-confirmed cases of human infection with avian influenza A(H7N9) virus.
A 35-year-old man from Wuxi City, Jiangsu Province became ill on March 17 and was admitted to a hospital on March 24. He is currently in critical condition.
A 72-year-old man from Fuzhou City, Fujian Province became ill on March 23 and was admitted to a hospital on March 27. He is currently in severe condition. The patient has a history of exposure to poultry.
A 65-year-old man from Shaoyang City, Hunan Province became ill on March 21 and was admitted to a hospital on March 29. He is currently in severe condition. The patient has a history of exposure to poultry.
On April 3, 2014, the NHFPC notified WHO of two additional laboratory-confirmed case of human infection with avian influenza A(H7N9) virus.
A 28-year-old man from Suzhou City, Jiangsu province became ill on March 23 and was admitted to a hospital on March 28. He is currently in asevere condition. The patient has a history of exposure to poultry.
A 68 year-old man from Guangzhou City, Guangdong province became ill on March 20 and was admitted to a hospital on March 24. He is currently in critical condition. The patient has a history of exposure to poultry.
The Chinese government has taken the following surveillance and control measures: strengthen surveillance and situation analysis; reinforce case management and treatment; and conduct risk communication with the public and release information.
The previous report of avian influenza A(H7N9) virus detection in live poultry exported from mainland China to Hong Kong SAR shows the potential for the virus to spread through movement of live poultry, at this time there is no indication that international spread of avian influenza A(H7N9) has occurred. However as the virus infection does not cause signs of disease in poultry, continued surveillance is needed. Further sporadic human cases of avian influenza A(H7N9) infection are expected in affected and possibly neighboring areas.
Should human cases from affected areas travel internationally, their infection may be detected in another country during or after arrival. If this were to occur, community level spread is unlikely as the virus does not have the ability to transmit easily among humans. Until the virus adapts itself for efficient human-to-human transmission, the risk of ongoing international spread of H7N9 virus by travelers is low.
WHO advises that travelers to countries with known outbreaks of avian influenza should avoid poultry farms, or contact with animals in live bird markets, or entering areas where poultry may be slaughtered, or contact with any surfaces that appear to be contaminated with feces from poultry or other animals. Travelers should also wash their hands often with soap and water. Travelers should follow good food safety and good food hygiene practices.
WHO does not advise special screening at points of entry with regard to this event, nor does it currently recommend any travel or trade restrictions.
As always, a diagnosis of infection with an avian influenza virus should be considered in individuals who develop severe acute respiratory symptoms while travelling or soon after returning from an area where avian influenza is a concern.
WHO encourages countries to continue strengthening influenza surveillance, including surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns, in order to ensure reporting of human infections under the IHR (2005), and continue national health preparedness actions.
Source: WHO
Expanded Screening Protocols Improve Early Detection of Candida auris at Mount Sinai Brooklyn
December 1st 2024Mount Sinai Brooklyn’s expanded Candida auris screening protocols identified more cases, enabling timely isolation and disinfection measures to prevent outbreaks and enhance patient safety in hospital settings.
Pioneering Advances in Sterilization: The Future of Infection Control
November 28th 2024Germitec, STERIS, ASP, and Zuno Medical are pioneering sterilization advancements with groundbreaking technologies that enhance SPD workflows, improve patient safety, and redefine infection control standards.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.